Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Clinical trial NCT02009761 · TERMINATED
Trial details
- NCT number
- NCT02009761
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-18
- Primary completion
- 2016-04-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.